The global Benzonase Endonuclease market size is predicted to grow from US$ 353 million in 2025 to US$ 504 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.
Benzonase endonuclease is a highly efficient, nonspecific nuclease enzyme that degrades all forms of DNA and RNA into small oligonucleotides of 2-5 base pairs. Derived from Serratia marcescens, this enzyme works under a wide range of conditions, including varying pH and salt concentrations, and is resistant to many chemical and thermal denaturation processes.
Benzonase is widely used in biopharmaceuticals, biotechnology, and research applications to remove nucleic acid contamination from protein samples, cell lysates, and viral preparations. Its high specificity and efficiency make it ideal for ensuring purity and improving downstream processing in workflows like chromatography, protein purification, and vaccine development.
Segmentation by Type:
- 5kU
- 25kU
- 50kU
- 100kU
- >100kU
Segmentation by Application:
- Biological Laboratory
- University Research Room
- Others
Market by Region:
- Americas
- APAC
- Europe
- Middle East & Africa
Company Coverage:
- RayBiotech
- TransGen Biotech
- AbMole BioScience
- GenScript
- Shanghai Biyuntian Biotechnology
- KACTUS
- ACROBiosystems Group
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Benzonase Endonuclease market?
- What factors are driving Benzonase Endonuclease market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Benzonase Endonuclease market opportunities vary by end market size?
- How does Benzonase Endonuclease break out by Type, by Application?
Frequently Asked Questions
What is the USP of the report? expand_more
What are the key content of the report? expand_more
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market